XML 50 R26.htm IDEA: XBRL DOCUMENT v3.25.3
Assets and Liabilities Held For Sale (Tables)
9 Months Ended
Sep. 30, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations
The following table summarizes the assets and liabilities of BioCryst Ireland that are classified as held for sale on the unaudited Condensed Consolidated Balance Sheet as of September 30, 2025 (in thousands):
September 30, 2025
Assets
Current assets:
Cash and cash equivalents$14,840 
Trade receivables10,285 
Inventory, net2,146 
Prepaid expenses and other current assets1,902 
Current assets held for sale29,173 
Non-current assets held for sale4,058 
Total assets held for sale$33,231 
Liabilities
Current liabilities:
Accounts payable$1,714 
Accrued expenses24,371 
Other current liabilities338 
Current liabilities held for sale26,423 
Non-current liabilities held for sale436 
Total liabilities held for sale$26,859